
Carbon Nanotubes in Eye Disease Research
Carbon nanotubes are tiny tubes of carbon that scientists are studying for eye disease. Learn 3 ways they may help one day, and what is still unproven.
Photodynamic nanoparticles are an early research idea. Learn how light-activated particles might one day help treat 2 eye diseases, and what is unproven.
By HindSight Eye CareEye Care Research

Medical review pending Updated
Photodynamic nanoparticles are tiny particles that react to light. Scientists are studying them as a more precise way to treat retinal diseases.
The work is still in the research stage, and no eye clinic offers it as standard treatment. Below is what the science may offer and what remains unknown.
Photodynamic therapy uses light to switch on a drug. With nanoparticles, light of one color switches on the particles themselves.
The particles then make a form of oxygen that can harm sick cells. Researchers hope this spares the healthy tissue nearby.
These nanoparticles typically include:
A light-sensitive core
A safe outer shell that the body tolerates well
Targeting molecules that guide the particles to the right place
Light-sensitive agents that respond to light
Researchers are looking at photodynamic nanoparticles for two eye diseases. The first is age-related macular degeneration (AMD), where in the wet form abnormal blood vessels grow and leak.
The particles are built to target those vessels, which could lower the risk of vision loss. The second is diabetic retinopathy, where damaged blood vessels in the retina harm sight, and the goal is to treat those vessels and leave healthy retina alone.
Neither use is proven in everyday care yet.
If research succeeds, these particles could aim treatment more precisely. Their tiny size may help them reach tissue and target cells, with less harm to tissue nearby.
Current treatments can affect healthy tissue, so a more targeted approach could mean fewer side effects. Researchers have not shown that yet.
Scientists are working on better aim, new particle designs and combined treatments. Clinical trials are testing whether these therapies are safe and work over the long term. Until results are in, your eye doctor can tell you which treatments are proven today.
For the best protection, have regular eye exams so problems are found early. Our complete eye exam checks your retina, and a dilated eye exam gives a closer look at the back of the eye. If you have diabetes, keep up with your diabetic eye exam.
See our post on related research into gold nanoparticles too. The American Optometric Association shares patient resources on targeted therapy and eye care.
Questions? Book your eye exam and ask us.
Are photodynamic nanoparticles available as a treatment now? No. They are still being studied, so they are not a standard treatment.
Are they safe? Studies are ongoing. The particles are made to be gentle on the body, but doctors must still test them with care in people.
What should I do about my retinal health today? See your eye doctor on schedule. Early care is still the best defense.
Written and published by HindSight Eye Care on December 25, 2024. This article is general information, not medical advice. Please talk with your eye doctor about your own care.
Want to know more? These independent eye health groups explain the topics on this page, starting with National Eye Institute. Each link opens in a new tab.

Carbon Nanotubes in Eye Disease Research
Carbon nanotubes are tiny tubes of carbon that scientists are studying for eye disease. Learn 3 ways they may help one day, and what is still unproven.

Gold Nanoparticles in Retinal Disease Diagnosis
Gold nanoparticles are tiny particles that researchers study to improve retinal imaging and early detection. Learn 5 key facts.

Smart Nanoprobes for Detecting Eye Inflammation
Smart nanoprobes are tiny sensors that researchers study to detect eye inflammation earlier. Learn 4 things to know about this early-stage science today.
Make time for your eyes. We’ll make you feel right at home.
Request an eye examOr call (352) 399-5412
Accessibility